|
1
|
020-44100840
|
DO 25-3339 DECLARACION(4-4) PROTOCOLO AR-DEX-22-01 (EXHALE-2), VISTO BUENO INVIMA NO. VINVIMA-25-0112185 DE FECHA 2025-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
ERESEARCH TECHNOLOGY GMBH
|
2025-09-30
|
ALEMANIA
|
1 Kgs
|
1 U
|
|
2
|
020-44100840
|
DO 25-3339 DECLARACION(3-4) PROTOCOLO AR-DEX-22-01 (EXHALE-2), VISTO BUENO INVIMA NO. VINVIMA-25-0112185 DE FECHA 2025-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
ERESEARCH TECHNOLOGY GMBH
|
2025-09-30
|
MALAYSIA
|
0.45 Kgs
|
5 U
|
|
3
|
020-44100840
|
DO 25-3339 DECLARACION(2-4) PROTOCOLO AR-DEX-22-01 (EXHALE-2), VISTO BUENO INVIMA NO. VINVIMA-25-0112185 DE FECHA 2025-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
ERESEARCH TECHNOLOGY GMBH
|
2025-09-30
|
TAIWAN (FORMOSA)
|
0.01 Kgs
|
1 U
|
|
4
|
020-44100840
|
DO 25-3339 DECLARACION(1-4) PROTOCOLO: AR-DEX-22-01 (EXHALE-2), NO REEMBOLSABLE POR TRATARSE DE IMPORTACIONES PARA ESTUD
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
ERESEARCH TECHNOLOGY GMBH
|
2025-09-30
|
MALAYSIA
|
0.23 Kgs
|
4 U
|
|
5
|
XXX-03131399
|
DO 25-3271 DECLARACION(1-3) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO.VINVIMA-25-0113697 DE FECHA 2025-08
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-09-17
|
UNITED STATES
|
16 Kgs
|
3 U
|
|
6
|
XXX-03063569
|
DO 25-3280 DECLARACION(1-2) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO. VINVIMA-25-0113697 DE FECHA 2025-0
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-09-17
|
UNITED STATES
|
5 Kgs
|
24 U
|
|
7
|
XXX-03063569
|
DO 25-3280 DECLARACION(2-2) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO.VINVIMA-25-0113697 DE FECHA 2025-08
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-09-17
|
UNITED STATES
|
56 Kgs
|
10 U
|
|
8
|
XXX-03131399
|
DO 25-3271 DECLARACION(3-3) PROTOCOLO AR-DEX-22-01 (EXHALE-2). VISTO BUENO INVIMA NO.VINVIMA-25-0113697 DE FECHA 2025-08
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-09-17
|
CHINA
|
0.55 Kgs
|
25 U
|
|
9
|
XXX-03131399
|
DO 25-3271 DECLARACION(2-3) PROTOCOLO AR-DEX-22-01. (EXHALE-2).NO REEMBOLSABLE POR TRATARSE DE IMPORTACIONES PARA ESTUD
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
MEDPACE REFERENCE LABORATORIES
|
2025-09-17
|
UNITED STATES
|
0.21 Kgs
|
0.21 KG
|
|
10
|
729-9236-1791
|
DO 25-2856 DECLARACION(1-1) PROTOCOLO AR-DEX-22-04, NOS ACOGEMOS AL ACUERDO DE PROMOCION COMERCIAL ENTRE COLOMBIA Y EST
|
WORLDWIDE CLINICAL TRIALS COLOMBIA SAS
|
YOURWAY TRANSPORT BIOPHARMA SERVICES
|
2025-08-29
|
UNITED STATES
|
0.72 Kgs
|
0.72 KG
|